Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B

Dow Jones

2025/05/28

By Robb M. Stewart

Brookfield Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion.

The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex.

Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs.

GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion.

Write to Robb M. Stewart at robb.stewart@wsj.com

(END) Dow Jones Newswires

May 28, 2025 09:47 ET (13:47 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2538229471"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2538229471\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2538229471?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-28 21:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2538229471","market":"other","top_or_hot":-1,"title":"Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/BN\">Brookfield</a> Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion. \n</p>\n<p>\n  The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex. \n</p>\n<p>\n  Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs. \n</p>\n<p>\n  GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 28, 2025 09:47 ET (13:47 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Brookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBrookfield, Caisse de Depot Buy Antylia Scientific From GTCR for $1.34B\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-05-28 21:47</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Robb M. Stewart \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/BN\">Brookfield</a> Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion. \n</p>\n<p>\n  The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex. \n</p>\n<p>\n  Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs. \n</p>\n<p>\n  GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  May 28, 2025 09:47 ET (13:47 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2360108059.USD","symbol_name":"BGF CIRCULAR ECONOMY \"A4\" (USD) INC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2538229471","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2538229471","pubTimestamp":1748440020,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Brookfield Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion.The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex.Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs.GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2360108059.USD":"BGF CIRCULAR ECONOMY \"A4\" (USD) INC","LU0061474960.USD":"天利环球焦点基金AU Acc","LU0557290698.USD":"施罗德环球可持续增长基金","LU2298321311.HKD":"BGF CIRCULAR ECONOMY \"A\" (HKDHDG) ACC","LU0528227936.USD":"富达环球人口趋势基金A-ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU1720051017.SGD":"Allianz Global Artificial Intelligence AT Acc H2-SGD","BK4535":"淡马锡持仓","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU0316494557.USD":"FRANKLIN GLOBAL FUNDAMENTAL STRATEGIES \"A\" ACC","LU1854104046.USD":"M&G (LUX) POSITIVE IMPACT \"A\" (USD) ACC","LU2357305700.SGD":"Allianz Global Artificial Intelligence ET H2-SGD","LU1548497426.USD":"安联环球人工智能AT Acc","LU1923622614.USD":"Natixis Thematics Meta R/A USD","LU2112291526.USD":"BGF WORLD HEALTHSCIENCE \"A4\" (USD) INC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)","LU0342679015.USD":"ALLIANZ GLOBAL EQUITY UNCONSTRAINED \"AT\" (USD) ACC","BK4588":"碎股","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00B19Z8W00.USD":"FTGF CLEARBRIDGE US LARGE CAP GROWTH \"A\" INC","IE00BFTCPJ56.SGD":"Janus Henderson Global Life Sciences A Acc SGD","BK4548":"巴美列捷福持仓","LU0011850046.USD":"贝莱德全球长线股票 A2 USD","LU0957791311.USD":"THREADNEEDLE (LUX) GLOBAL FOCUS \"ZU\" (USD) ACC","AVTR":"Avantor, Inc.","LU0882574055.USD":"富达全球健康医疗A ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","TMO":"赛默飞世尔","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU0823416689.USD":"BNP PARIBAS HEALTH CARE INNOVATORS \"C\" (USD) ACC","IE00B1BXHZ80.USD":"Legg Mason ClearBridge - US Appreciation A Acc USD","BK4121":"生命科学工具和服务","LU0234572021.USD":"高盛美国核心股票组合Acc","BK4581":"高盛持仓","LU2433249047.HKD":"THEMATICS META \"R/A\" (HKD) ACC","LU1923621640.USD":"Natixis Thematics Water R/A USD","LU2125910179.SGD":"Natixis Thematics Water H-R/A SGD","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","IE0034235188.USD":"PINEBRIDGE GLOBAL FOCUS EQUITY \"A\" (USD) ACC","LU1988902786.USD":"FULLERTON LUX FUNDS GLOBAL ABSOLUTE ALPHA \"I\" (USD) ACC","IE00B19Z9505.USD":"美盛-美国大盘成长股A Acc","LU2764263039.SGD":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (SGDHDG) ACC","LU2764263203.CNY":"BGF GLOBAL UNCONSTRAINED EQUITY \"A2\" (CNYHDG) ACC","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","IE0009355771.USD":"骏利亨德森环球生命科技A Acc","LU2125910336.SGD":"Natixis Thematics Water R/A SGD","LU0266013472.USD":"AXA WF - Framlington Longevity Economy A Cap USD","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H"},"translate_title":"Brookfield、Caisse de Depot以$1.34 B从GTCR手中收购Antylia Scientific","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AVTR":0.9,"TMO":0.9},"content_text":"By Robb M. Stewart \n\n\n \n\n\nBrookfield Asset Management and Caisse de depot et placement du Quebec have bought life-sciences company Antylia Scientific from private-equity firm GTCR for roughly $1.34 billion. \n\n\n  The purchase of the Illinois-based business marks Brookfield's latest transaction in the U.S. industrial and manufacturing sector, following a deal earlier this year for electric heat-trace systems company Chemelex. \n\n\n  Antylia manufacturers and sells products that support the accuracy and repeatability of processes in labs. \n\n\n  GTCR bought Antylia from Thermo Fisher Scientific in a carve-out transaction in 2014, and has invested in the company to help expand its geographic reach and portfolio of products over the years. Antylia has since 2014 completed 15 acquisitions of complementary life-science tools and diagnostic-controls businesses, and in late 2021 it separated and divested its Masterflex bioprocessing business segment to Avantor in an all-cash transaction that valued the unit at $2.9 billion. \n\n\n \n\n\n  Write to Robb M. Stewart at robb.stewart@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 28, 2025 09:47 ET (13:47 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}